参考文献/References:
[1]汤钊猷.现代肿瘤学[M].上海:复旦大学出版社,2011:706-707.
[2]Aapro M.Searching for perfection:further progress in management of chemotherapy-induced nausea and vomiting-introduction[J].Support Care Cancer,2018,26(1):35-37.
[3]Rapoport BL.Delayed Chemotherapy-Induced Nausea and Vomiting:Pathogenesis,Incidence,and Current Management[J].Front Pharmacol,2017,8(5):19.
[4]Darmani NA,Ray AP.Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting[J].Chemical Reviews,2009,109(7):3158-3199.
[5]Affronti ML,Bubalo J.Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy[J].Cancer Manag Res,2014(6):329-337.
[6]Rojas C,Raje M,Tsukamoto T,et al.Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis[J].European Journal of Pharmacology,2014,722(1):26-37.
[7]Doggrell SA.Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV)-is there still a role after comparison with palonosetron[J].Expert Opin Pharmacother,2017,18(10):1-8.
[8]于世英,印季良,秦叔逵,等.肿瘤治疗相关呕吐防治指南(2014版)[J].临床肿瘤学杂志,2014,19(3):263-273.
[9]Saito H,YoshizawaH,Yoshimori K,et al.Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin:a multicenter,randomised,double-blind,placebo-controlled phase 3 trial[J].Ann Oncol,2013,24(4):1067-63.
[10]Chelkeba L,Gidey K,Mamo A,et al.Olanzapine for chemotherapy-induced nausea and vomiting:systematic review and meta-analysis[J].Pharmacy Practice,2017,15(1):877.
[11]李永亮,郑红梅,刘伯轩,等.昂丹司琼联合地西泮防治顺铂化疗所致恶心呕吐的临床观察[J].中国医学创新,2014,11(8):38-40.
[12]肖冲,由凤鸣,陈株生,等.以肾为生痰之本论治化疗后呕吐[J].云南中医中药杂志,2015,36(6):18-20.
[13]王海威.加味半夏泻心汤治疗迟发性化疗相关性呕吐的临床研究[D].北京中医药大学,2014.
[14]寇永锋,门九章.从脾胃论治肺癌化疗性呕吐[J].中国临床研究,2017,30(2):262-264.
[15]丁明翠,张可,牟玲.恶性肿瘤化疗后呕吐的中医药治疗临床研究[J].中医临床研究,2017,9(12):127-128.
[16]蔚振宇,周洁.周洁教授治疗恶性肿瘤化疗后呕吐的经验特色[J].黑龙江中医药,2016,45(1):50.
[17]涂小华.四君子汤多糖对IEC-6细胞迁移多胺信号通路钙离子调控影响的研究[D].广州中医药大学,2016.
[18]姚德蛟,蔡懿,陈玉.脾肾合剂联合格拉司琼对化疗呕吐神经递质影响实验研究[J].中药与临床,2013,4(1):29-30,36.
[19]陈株生,由凤鸣,肖冲,等.化疗后呕吐的肾脑胃论治探讨[J].世界中医药,2015,10(4):507-510.
[20]刘建军,吴淑霞,冯海英,等.中医辨证干预对化疗所致呕吐的临床效果观察[J].四川中医,2015,33(12):134-136.
[21]张绍文,叶佐荣.小柴胡汤合蒿芩清胆汤治疗肺癌化疗所致恶心呕吐临床观察[J].新中医,2016,48(5):214-216.
[22]朱伟坚,徐妍,周静珠,等.电针耳迷走神经防治化疗后恶心呕吐的疗效观察[J].山东中医杂志,2016,35(5):415-419.
[23]Rithirangsriroj K,Manchana T,Akkayagorn L.Efficacy of a cupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients[J].Gynecologic Oncology,2015,136(1):82-86.
[24]谢燕达.隔药灸联合昂丹司琼治疗含铂方案CINV脾虚湿困证的临床观察[D].北京中医药大学,2016.
[25]张燕,林世东,王彬彬.半夏泻心汤联合胃复安足三里穴位注射防治化疗后呕吐的临床研究[J].陕西中医药大学学报,2016,39(6):92-93.
[26]王芳.辨证穴位注射对肿瘤化疗所致恶心呕吐及免疫功能影响的临床研究[D].安徽中医药大学,2014.
相似文献/References:
[1]宁尚波,杨东红,付 爽.选择性动脉灌注化疗在口腔癌治疗中的进展[J].医学信息,2018,31(03):28.[doi:10.3969/j.issn.1006-1959.2018.03.009]
NING Shang-bo,YANG Dong-hong,FU Shuang.Progress of Selective Arterial infusion Chemotherapy in the Treatment of Oral Cancer[J].Journal of Medical Information,2018,31(21):28.[doi:10.3969/j.issn.1006-1959.2018.03.009]
[2]李杰萍,姜翠红,管树荣,等.化疗患者PICC置管前后心理体验的质性研究[J].医学信息,2018,31(05):164.[doi:10.3969/j.issn.1006-1959.2018.05.060]
I Jie-ping,JIANG Cui-hong,GUAN Shu-rong,et al.Qualitative Study of Psychological Experience before and after PICC Catheterization in Patients undergoing Chemotherapy[J].Journal of Medical Information,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.05.060]
[3]张祖雪,吴治敏,王 艳.1例滋养细胞疾病患者化疗后并发严重口腔溃疡护理[J].医学信息,2019,32(01):183.[doi:10.3969/j.issn.1006-1959.2019.01.060]
ZHANG Zu-xue,WU Zhi-min,WANG Yan.1 Case of Trophoblastic Disease with Severe Oral Ulcer Care after Chemotherapy[J].Journal of Medical Information,2019,32(21):183.[doi:10.3969/j.issn.1006-1959.2019.01.060]
[4]庞小坤,韩 梅,江心灿,等.当归补血汤治疗肿瘤化疗不良反应随机对照临床试验的Meta分析[J].医学信息,2019,32(02):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
Pang Xiao-kun,Han Mei,Jiang Xin-can,et al.Meta-analysis of a Randomized Controlled Clinical Trial of Angelica Buxue Decoction in the Treatment of Adverse Reactions to Chemotherapy[J].Journal of Medical Information,2019,32(21):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
[5]万 卉.中西医结合护理改善乳腺癌化疗患者生活质量的临床观察[J].医学信息,2019,32(11):185.[doi:10.3969/j.issn.1006-1959.2019.11.058]
WAN Hui.Clinical Observation on Integrating Traditional Chinese Medicine with Western Medicine to
Improve the Quality of Life of Patients with Breast Cancer Chemotherapy[J].Journal of Medical Information,2019,32(21):185.[doi:10.3969/j.issn.1006-1959.2019.11.058]
[6]龚建忠,韦 燕,潘琦津,等.锌剂防治鼻咽癌同步放化疗患者放射性口咽炎的效果分析[J].医学信息,2019,32(17):63.[doi:10.3969/j.issn.1006-1959.2019.17.020]
GONG Jian-zhong,WEI Yan,PAN Qi-jin,et al.Effect of Zinc on Prevention and Treatment of Radiation Oropharyngeal Mucositis in Patients with Nasopharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy[J].Journal of Medical Information,2019,32(21):63.[doi:10.3969/j.issn.1006-1959.2019.17.020]
[7]吴 刚,袁华兵.阿瑞匹坦对于改善Ⅲ~Ⅳ期颅内胶质瘤患者CINV的研究[J].医学信息,2019,32(13):87.[doi:10.3969/j.issn.1006-1959.2019.13.024]
WU Gang,YUAN Hua-bing.Study on the Effect of Aprepitant on Improving CINV in Patients with
Stage III~IV Intracranial Glioma[J].Journal of Medical Information,2019,32(21):87.[doi:10.3969/j.issn.1006-1959.2019.13.024]
[8]刘 筠.异环磷酰胺与依托泊苷联合治疗
复发卵巢癌的临床效果[J].医学信息,2019,32(13):143.[doi:10.3969/j.issn.1006-1959.2019.13.044]
LIU Jun.Clinical Effect of Combination of Ifosfamide and Etoposide inTreatment of Recurrent Ovarian Cancer[J].Journal of Medical Information,2019,32(21):143.[doi:10.3969/j.issn.1006-1959.2019.13.044]
[9]张骁燕.植入式输液港与PICC置管应用于乳腺癌术后化疗的优势[J].医学信息,2019,32(21):184.[doi:10.3969/j.issn.1006-1959.2019.21.063]
ZHANG Xiao-yan.Implantable Infusion Port and PICC Catheter for the Advantages of Postoperative Chemotherapy for Breast Cancer[J].Journal of Medical Information,2019,32(21):184.[doi:10.3969/j.issn.1006-1959.2019.21.063]
[10]王 平,苏志红.参芪扶正注射液辅助治疗晚期胃癌的效果[J].医学信息,2019,32(24):50.[doi:10.3969/j.issn.1006-1959.2019.24.016]
WANG Ping,SU Zhi-hong.Effect of Shenqi Fuzheng Injection on Adjuvant Treatment of Advanced Gastric Cancer[J].Journal of Medical Information,2019,32(21):50.[doi:10.3969/j.issn.1006-1959.2019.24.016]